Investors Sell Catalent After Mixed Quarter

Health care remains one of the best-performing sectors year-to-date, down just 9.62%, but it’s a broad sector that includes a lot of subindustries. As a result, performance can vary widely depending on the industry and market-cap segment.

Today we head from the $16 billion pharmaceuticals company Catalent, which reported better-than-expected earnings, but revenues fell short of expectations. Additionally, its revenue and full-year outlook came in below estimates.

Overall, investors did not appear thrilled with what they heard from the company, sending the stock down 7.44% towards its YTD lows. 📉

More in   Earnings

View All

Buyers Move Beyond Tech

Animal spirits have been a big theme of this newsletter since October, and boy, are things getting wild. While the mainstream media continues focusing on tech giants like Nvidia, investors and traders are searching far and wide for new opportunities to squeeze the shorts and make a killing. 🕵️‍♂️

Today’s surefire sign of this speculative fervor building in the market is everyone’s favorite non-meat meat stock, Beyond Meat. 🫨

Read It

Headline Vs. Reality (Media Edition)

One of the perplexing things about markets is that sometimes headlines don’t necessarily match the reaction in markets. And that was certainly the case today in struggling media giant Warner Bros. Discovery. 📰

The Hollywood Reporter wrote an article boasting that Warner Bros became the first Hollywood conglomerate to turn a full-year streaming profit ($103 million).  

Read It

The Internet Of Things Grows Wings

While sentiment surges around crypto and artificial intelligence, it’s no surprise to see that hype around the “Internet of Things” company Samsara is also popping off. 🤩

The stock jumped to fresh all-time highs in the after-hours session following better-than-expected results. Its fourth-quarter revenues of $276.3 million topped estimates of $258.3 million, with its adjusted loss also narrower than anticipated. 💪

Read It

Dave Rides The Speculation Wave

Neobanks that came public during the pandemic at insane valuations and got crushed over the last few years are roaring back in the current environment. 🏦

Dave Inc. is a digital banking service primarily focusing on cash advances, working off tips and subscription fees rather than overdraft fees. That was a solid business in the ZIRP era of cheap money but faced a reckoning in a higher interest rate environment. 💸

Read It